Literature DB >> 6340471

Distribution of break points in human structural rearrangements.

Y Nakagome, T Matsubara, H Fujita.   

Abstract

We attempted to resolve the issue on the location of breakages in patients with structural rearrangements, that is, whether they are located within the light band or are at the interface between a G-dark and a G-light band. Three types of structural rearrangements (inverted duplications, isodicentrics, and rings) were studied as they are capable of providing information not obtainable from other rearrangements because of reasons given in the RATIONALE. We found that break points are primarily located within the G-light bands; a small number of breaks are located in G-dark bands. Breakages at the interface were exceedingly rare. The possibility that they are, in fact, located at the interface of subbands within either light or dark bands appears tenuous. Contrary to what is described in the literature, terminal deletions are not useful in the determining of break points.

Entities:  

Mesh:

Year:  1983        PMID: 6340471      PMCID: PMC1685530     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  54 in total

1.  Three cases of ring chromosome 2, one derived from a paternal 2/6 translocation.

Authors:  P Maraschio; C Danesino; A Garau; V Saputo; V Vigi; S Volpato
Journal:  Hum Genet       Date:  1979-04-27       Impact factor: 4.132

2.  A ring 14 chromosome with deleted short arm.

Authors:  A P Amarose; E Dorus; P R Huttenlocher; S Csaszar
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

3.  Ring-18 and isopseudodicentric-18 in the same child: a hypothesis to account for common origin.

Authors:  K Madan; L Vlasveld; P G Barth
Journal:  Ann Genet       Date:  1981

4.  Study of two cases of ring 13 chromosome using high-resolution banding.

Authors:  I M Jones; C G Palmer; D D Weaver; M E Hodes
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

5.  Ring chromosome 15 in a male adult with radial defects. Evaluation of the phenotype.

Authors:  P Meinecke; T Koske-Westphal
Journal:  Clin Genet       Date:  1980-12       Impact factor: 4.438

6.  Ring chromosome 10:46,XX,r(10)(p15 leads to q26).

Authors:  R Tsukino; N Tsuda; T Dezawa; T Ishii; M Koike
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

7.  Further dicentric X isochromosomes and deletions, and a new structure i(X)(pter to q2102 to pter).

Authors:  A Daniel; T Saville; D B Southall
Journal:  J Med Genet       Date:  1979-08       Impact factor: 6.318

8.  Ring chromosome 15: phenotype, Ag-NOR analysis, secondary aneuploidy, and associated chromosome instability.

Authors:  D H Ledbetter; V M Riccardi; W W Au; D P Wilson; G P Holmquist
Journal:  Cytogenet Cell Genet       Date:  1980

9.  Ring chromosome 2 in a child with growth failure and few congenital abnormalities.

Authors:  N V Vigfusson; K J Kapstafer; M A Lloyd
Journal:  Am J Med Genet       Date:  1980

10.  13q-/r(13) mosaicism.

Authors:  N Niikawa; T Tamura; F Tomiyasu; T Kajii
Journal:  J Med Genet       Date:  1980-08       Impact factor: 6.318

View more
  3 in total

1.  Analysis of X-ray-induced aberrations in human chromosome 5 using high-resolution multicolour banding FISH (mBAND).

Authors:  C Johannes; I Chudoba; G Obe
Journal:  Chromosome Res       Date:  1999       Impact factor: 5.239

2.  The "loss" of centromeres from chromosomes of aged women.

Authors:  Y Nakagome; T Abe; S Misawa; T Takeshita; K Iinuma
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

3.  FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality.

Authors:  J A Fantes; E Boland; J Ramsay; D Donnai; M Splitt; J A Goodship; H Stewart; M Whiteford; P Gautier; L Harewood; S Holloway; F Sharkey; E Maher; V van Heyningen; J Clayton-Smith; D R Fitzpatrick; G C M Black
Journal:  Am J Hum Genet       Date:  2008-03-27       Impact factor: 11.025

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.